Kollmar R, Schellinger P D, Bardutzky J, Meisel F, Schwaninger M
Neurologische Klinik, Universität Heidelberg.
Nervenarzt. 2002 Dec;73(12):1183-5. doi: 10.1007/s00115-002-1393-1.
Myxedema coma is a rare and life-threatening complication of untreated hypothyroidism. Therefore, it must be part of the differential diagnosis in comatose patients. We report one patient who presented with CO(2) narcosis,hypothermia, bradycardia,hyporeflexia, tetraparesis, ascitis, pleural effusions, and heart insufficiency. Examination of the CSF, cranial CT, MRI, and MR angiography were normal. In suspicion of myxedema coma,the patient was treated with high dose L-thyroxine and hydrocortisone for preventing secondary adrenal insufficiency. A fast clinical recovery, decreased T4 (7.2 ng/l) and T3 (0.93 ng/l), and increased TSH (20.19 mU/l) together with the following anamnesis of radio iodine therapy and insufficient thyroxine intake confirmed the diagnosis. In conclusion, treatment of the myxedema coma must be started as soon as the laboratory results are confirmatory, since its course depends on the time of initiation of treatment.
黏液性水肿昏迷是未经治疗的甲状腺功能减退症罕见且危及生命的并发症。因此,它必须作为昏迷患者鉴别诊断的一部分。我们报告了一名患者,其表现为二氧化碳麻醉、体温过低、心动过缓、反射减退、四肢轻瘫、腹水、胸腔积液和心力衰竭。脑脊液检查、头颅CT、MRI和磁共振血管造影均正常。怀疑为黏液性水肿昏迷后,该患者接受了大剂量左甲状腺素和氢化可的松治疗,以预防继发性肾上腺功能不全。快速的临床恢复、T4(7.2 ng/l)和T3(0.93 ng/l)降低以及TSH(20.19 mU/l)升高,再加上随后放射性碘治疗和甲状腺素摄入不足的病史,证实了诊断。总之,一旦实验室结果得到证实,就必须立即开始黏液性水肿昏迷的治疗,因为其病程取决于治疗开始的时间。